Cingulate Presents at NobleCon18
April 26, 2022 12:27 ET
|
Cingulate Inc.
KANSAS CITY, Kan., April 26, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug...
IBN to Serve as Platinum Sponsor of NobleCon18, NetworkNewsWire Named Official NewsWire
April 19, 2022 08:35 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, April 19, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (InvestorBrandNetwork), an innovative corporate communications agency and content distributor with 50+ brands, is pleased to...